CT或MRI识别的大梗死核心患者接受与不接受静脉溶栓的血管内取栓结局对比
这项回顾性研究纳入法国ETIS登记中2015年1月至2022年1月连续接受血管内取栓的大血管闭塞所致急性缺血性卒中且大梗死核心(ASPECTS 0-5)成人患者1408例,比较取栓前静脉溶栓与单纯取栓的结局。经逆概率治疗加权调整后,静脉溶栓加取栓与更高的90天良好结局、功能独立、残疾程度改善、早期神经功能改善和成功再灌注相关,两组24小时内脑出血和90天死亡率相似。
要点
- 大梗死核心(ASPECTS 0-5)患者取栓前接受静脉溶栓与更高90天良好结局相关(OR 1.24)。
- 静脉溶栓加取栓组成功再灌注率更高(OR 1.43),24小时脑出血与90天死亡率与单纯取栓相似。
- 该获益为观察性研究结果,作者认为静脉溶栓前治疗似乎提供临床获益。
核心结论
- 在CT或MRI识别的大梗死核心(ASPECTS 0-5)的大血管闭塞所致急性缺血性卒中患者中,取栓前静脉溶栓似乎较单纯取栓提供临床获益。
研究设计与样本
- 回顾性研究,纳入法国ETIS登记2015年1月至2022年1月连续接受血管内取栓的大血管闭塞所致急性缺血性卒中且大梗死核心(ASPECTS 0-5)成人患者1408例,采用逆概率治疗加权调整分析。
诊断标准与关键数值
- 大梗死核心定义为Alberta卒中项目早期CT评分(ASPECTS)0-5分,由CT或MRI识别;主要结局为90天良好结局(改良Rankin量表[mRS]评分0-3)。
临床应用与阅片要点
- 作者认为,对于CT或MRI识别的大梗死核心(ASPECTS 0-5)的大血管闭塞所致急性缺血性卒中患者,取栓前静脉溶栓似乎提供临床获益。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Whether intravenous thrombolysis (IVT) prior to endovascular thrombectomy (EVT) provides additional benefits in patients with acute ischemic stroke (AIS) and a large infarct core (LIC) remains unclear. Purpose To examine whether treatment with IVT before EVT is beneficial in patients with LIC identified with CT or MRI (Alberta Stroke Program Early CT score 0-5). Materials and Methods This retrospective study included consecutive adult patients diagnosed with AIS due to large vessel occlusion (LVO) and LIC treated with EVT who were enrolled in the ETIS (Endovascular Treatment in Ischemic Stroke) Registry in France between January 2015 and January 2022. The primary outcome measure was a favorable outcome (modified Rankin Scale [mRS] score 0-3) at 90 days. Secondary outcomes included functional independence (mRS score 0-2) at 90 days, improvement in degree of disability (ordinal shift in mRS score toward a better outcome) at 90 days, early neurologic improvement at 24 hours, and successful reperfusion (modified Thrombolysis in Cerebral Infarction score of 2b or higher). Safety outcomes included symptomatic intracerebral hemorrhage within 24 hours and mortality at 90 days. Inverse probability of treatment weighting (IPTW)-adjusted analysis was used to assess the treatment effect of IVT adjusted for baseline variables. Results Of 1408 patients (mean age, 68.3 years ± 15.4 [SD]; 789 men), 654 (46.4%) were treated with IVT prior to EVT. In the IPTW-adjusted data set, IVT plus EVT was associated with a higher rate of favorable outcome at 90 days (odds ratio [OR], 1.24 [95% CI: 1.05, 1.46]; P = .01), functional independence at 90 days (OR, 1.47 [95% CI: 1.22, 1.77]; P < .001), improvement in degree of disability at 90 days (common OR, 1.30 [95% CI: 1.13, 1.49]; P < .001), early neurologic improvement (OR, 1.26 [95% CI: 1.07, 1.49]; P = .005), and successful reperfusion (OR, 1.43 [95% CI: 1.14, 1.79]; P = .002) than EVT alone. Rates of brain hemorrhage within 24 hours and mortality at 90 days were similar between groups. Conclusion In patients with AIS due to LVO with LIC identified with CT or MRI, treatment with IVT before EVT appeared to provide a clinical benefit over EVT alone. Clinical trial registration no. NCT03776877 © RSNA, 2023 Supplemental material is available for this article. See also the editorial by Kallmes and Rabinstein in this issue.
引用
- Derraz I, Moulin S, Gory B, et al. Endovascular Thrombectomy Outcomes with and without Intravenous Thrombolysis for Large Ischemic Cores Identified with CT or MRI. Radiology. 2023. PMID: 37847131. doi:10.1148/radiol.230440
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。